32 results
8-K
EX-1.1
ATXS
Astria Therapeutics Inc
4 Mar 24
Entry into a Material Definitive Agreement
5:22pm
or will comply in all material respects with the requirements of Rule 433 under the Securities Act including timely filing with the Commission or retention
8-K
EX-1.1
ATXS
Astria Therapeutics Inc
31 Jan 24
Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering
9:00am
, including timely filing with the Commission, retention and legending, as applicable, and each such free writing prospectus, as of its issue date
8-K
EX-1.1
duoqj4fqqv2wsa
12 Oct 23
Astria Therapeutics Announces Pricing of $64 Million Underwritten Offering
5:04pm
8-K
EX-1.1
h6lw1j
15 Dec 22
Astria Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock
5:18pm
8-K
EX-1.1
zrjxb8jcf
30 Jun 21
Entry into a Material Definitive Agreement
4:25pm
8-K
EX-2.1
prl0gfp5b02 7883aiyf
29 Jan 21
Entry into a Material Definitive Agreement
8:05am
8-K
EX-1.1
ajd6 aasdw5jppq
30 Jan 20
Catabasis Pharmaceuticals Announces Pricing of $23 Million Underwritten Public Offering
4:03pm